Magainin Pharm (MAGN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Magainin Pharm (MAGN)

MAGN 8.625

-2.1%

9:43 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Shlepper who wrote (155)	10/26/1998 12:30:00 AM
From: Dave K	Read Replies (1) of 233

Shep, decided to spend a few hours checking around and found wealth of material on Squalamine/Angiogenesis and IL9 work/Asthma published lately. The Journal of Biological Chemistry is published by the American Society for Biochemistry and Molecular Biology. jbc.org Lately, due to bad past experiences, I've increased my focus on management (both on business savvy and scientific achievements). I don't know if MAGN management are business savvy (only time will tell) but felt a sense of encouragement during a conversation I had with Mike Zasloff a few months back (before he was promoted to top slot and probably now inaccessible). Along the scientific achievement angle I found this to be appealing... amcity.com Making rounds Dr. Michael Zasloff, executive vice president of Plymouth Meeting-based Magainin Pharmaceuticals Inc., received the Solomon A. Berson Medical Alumni Achievement Award in Basic Sciences from the New York University School of Medicine on April 25. The alumni achievement award recognizes Zasloff's contributions to the understanding of innate immunity and host defense systems, including the discovery of magainins ... Magainin also presented new data on its asthma gene candidates, Interleukin-9 and the IL-9 receptor at the International Conference of the American Lung Association/American Thoracic Society in Chicago last week. Company officials said the data provides further evidence that the company's genomics group has discovered an "important asthma pathway," which could lead to the development of asthma therapeutics ... Not ready to mortgage the house but I do feel quietly optimistic long term. Cheers, Dave

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next